English
English 简体中文
0760-89920979
0760-89920979
16984638634831788
News
Home> News / Company news /
09-28
2025
调亮了d6112(1)(1)(1)(1)
Patient enrollment has been completed for the RAB001 Phase II clinical trial!
View More>
09-10
2025
IMG_8184(1)
Rabpharma Successfully Closes Oversubscribed Series A++ Funding Round to Accelerate R&D Progress​
View More>
06-20
2025
17504044479908368(1)
​Early-Stage Osteonecrosis Phase II Clinical Trial Patient Recruitment​​
View More>
05-30
2025
594bf575b1447205f44dc9f5cc5b7f7(1)
The Fifth Meeting of the First Session of the Board of Directors & 2024 Annual Shareholders' Meeting of Rabpharma Successfully Concluded​​
View More>
03-01
2025
17508328469373239(1)
​Phase II Clinical Trial of RAB001 Officially Launched at Beijing Jishuitan Hospital and The Third Affiliated Hospital of Guangzhou University of Chinese Medicine!​​
View More>
1234
0760-89920979
info@rabpharma.com